Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia.

Background And Aim: There are no globally approved, distinguishing criteria enabling the classification of gastric adenomas and intramucosal carcinomas for differential diagnosis of noninvasive neoplasia (NIN).

Methods: Next-generation sequencing of 50 cancer-related genes was undertaken on 68 pathologically diagnosed microdissected gastric neoplasms (25 adenomas, 27 intramucosal carcinomas, and 16 submucosal carcinomas) obtained during endoscopic submucosal dissection. Findings from magnifying endoscopy with narrow-band imaging (M-NBI) of 52 NINs (the 25 adenomas and 27 intramucosal carcinomas) were compared with these data.

Results: Among all 68 neoplasms, the most frequently mutated genes were (76% in adenoma, 11.1% in intramucosal carcinoma, and 0% in submucosal carcinoma;  < 0.001) and in intramucosal and submucosal carcinomas (8% in adenoma, 48.1% in intramucosal carcinoma, and 75% in submucosal carcinoma;  < 0.001). Dividing the NIN neoplasms into five groups according to their mutational status (A1: mutation, A2:  + α mutation, B:  +  mutation, C: mutation, D: no mutation in either or ) resulted in almost identical diagnoses by pathology and M-NBI for groups A1 (12/13, 92%), C (12/13, 92%), and D (16/17, 94%) but not for groups A2 (3/7, 43%) or B (0/2, 0%). This finding implies that NINs with the  + α mutation have carcinoma-like endoscopic features despite most being judged as adenomas by pathology.

Conclusion: A diagnosis of NINs by pathology or M-NBI in the subset of gastric tumors classified by cancer-related mutations is not completely identical, suggesting the possible additional role of M-NBI in diagnosing NINs. Further studies are needed to confirm this.